Measuring and modeling apoptosis in single cells

Cell

Volumn 144, Issue 6, 2011, Pages 926-939

  Spencer, Sabrina L ^a,b   Sorger, Peter K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE;

APOPTOSIS; BIOLOGICAL MODEL; CYTOLOGY; MATHEMATICAL MODEL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; REVIEW;

EID: 79952635820     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2011.03.002     Document Type: Review

References (93)

1. Albeck, J., Macbeath, G., White, F., Sorger, P., Lauffenburger, D., and Gaudet, S. (2006). Collecting and organizing systematic sets of protein data. Nat. Rev. Mol. Cell Biol. 7, 803-812.
2. Albeck, J.G., Burke, J.M., Aldridge, B.B., Zhang, M., Lauffenburger, D.A., and Sorger, P.K. (2008a). Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol. Cell 30, 11-25. (Pubitemid 351470145)
3. Albeck, J.G., Burke, J.M., Spencer, S.L., Lauffenburger, D.A., and Sorger, P.K. (2008b). Modeling a snap-action, variable-delay switch controlling extrinsic cell death. PLoS Biol. 6, 2831-2852.
4. Ashall, L., Horton, C.A., Nelson, D.E., Paszek, P., Harper, C.V., Sillitoe, K., Ryan, S., Spiller, D.G., Unitt, J.F., Broomhead, D.S., et al. (2009). Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription. Science 324, 242-246.
5. Bagci, E.Z., Vodovotz, Y., Billiar, T.R., Ermentrout, G.B., and Bahar, I. (2006). Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. Biophys. J. 90, 1546-1559.
6. Bentele, M., Lavrik, I., Ulrich, M., Stosser, S., Heermann, D.W., Kalthoff, H., Krammer, P.H., and Eils, R. (2004). Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J. Cell Biol. 166, 839-851. (Pubitemid 39249835)
7. Betti, C.J., Villalobos, M.J., Jiang, Q., Cline, E., Diaz, M.O., Loredo, G., and Vaughan, A.T. (2005). Cleavage of the MLL gene by activators of apoptosis is independent of topoisomerase II activity. Leukemia 19, 2289-2295. (Pubitemid 41741626)
8. Bhola, P.D., and Simon, S.M. (2009). Determinism and divergence of apoptosis susceptibility in mammalian cells. J. Cell Sci. 122, 4296-4302.
9. Borges, J.L., and Hurley, A. (1999). Collected Fictions (London: Allen Lane The Penguin Press).
10. Calzone, L., Tournier, L., Fourquet, S., Thieffry, D., Zhivotovsky, B., Barillot, E., and Zinovyev, A. (2010). Mathematical modelling of cell-fate decision in response to death receptor engagement. PLoS Comput. Biol. 6, e1000702.
11. Chabner, B., and Longo, D.L. (2006). Cancer Chemotherapy and Biotherapy: Principles and Practice, Fourth Edition (Philadelphia: Lippincott Willians & Wilkins).
12. Chen, C., Cui, J., Lu, H., Wang, R., Zhang, S., and Shen, P. (2007). Modeling of the role of a Bax-activation switch in the mitochondrial apoptosis decision. Biophys. J. 92, 4304-4315. (Pubitemid 46910545)
13. Chen, W.W., Niepel, M., and Sorger, P.K. (2010). Classic and contemporary approaches to modeling biochemical reactions. Genes Dev. 24, 1861-1875.
14. Chipuk, J.E., Bouchier-Hayes, L., and Green, D.R. (2006). Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ. 13, 1396-1402. (Pubitemid 44057475)
15. Chipuk, J.E., and Green, D.R. (2008). How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. 18, 157-164.
16. Cohen, A.A., Geva-Zatorsky, N., Eden, E., Frenkel-Morgenstern, M., Issaeva, I., Sigal, A., Milo, R., Cohen-Saidon, C., Liron, Y., Kam, Z., et al. (2008). Dynamic proteomics of individual cancer cells in response to a drug. Science 322, 1511-1516.
17. Condeelis, J., and Weissleder, R. (2010). In vivo imaging in cancer. Cold Spring Harb. Perspect. Biol. 2, a003848.
18. Deng, J., Carlson, N., Takeyama, K., Dal Cin, P., Shipp, M., and Letai, A. (2007). BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 12, 171-185.
19. Dussmann, H., Rehm, M., Concannon, C.G., Anguissola, S., Wurstle, M., Kacmar, S., Voller, P., Huber, H.J., and Prehn, J.H. (2010). Single-cell quantification of Bax activation and mathematical modelling suggest pore formation on minimal mitochondrial Bax accumulation. Cell Death Differ. 17, 278-290.
20. Edgington, L.E., Berger, A.B., Blum, G., Albrow, V.E., Paulick, M.G., Lineberry, N., and Bogyo, M. (2009). Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat. Med. 15, 967-973.
21. Eissing, T., Conzelmann, H., Gilles, E.D., Allgower, F., Bullinger, E., and Scheurich, P. (2004). Bistability analyses of a caspase activation model for receptor-induced apoptosis. J. Biol. Chem. 279, 36892-36897.
22. Eissing, T., Allgower, F., and Bullinger, E. (2005). Robustness properties of apoptosis models with respect to parameter variations and intrinsic noise. Syst. Biol. (Stevenage) 152, 221-228.
23. Fadeel, B., Orrenius, S., and Zhivotovsky, B. (1999). Apoptosis in human disease: a new skin for the old ceremony? Biochem. Biophys. Res. Commun. 266, 699-717.
24. Faeder, J.R., Blinov, M.L., and Hlavacek, W.S. (2009). Rule-based modeling of biochemical systems with BioNetGen. Methods Mol. Biol. 500, 113-167.
25. Falschlehner, C., Emmerich, C.H., Gerlach, B., and Walczak, H. (2007). TRAIL signalling: decisions between life and death. Int. J. Biochem. Cell Biol. 39, 1462-1475.
26. Ferrell, J.E., Jr., and Machleder, E.M. (1998). The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 280, 895-898.
27. Fricker, N., Beaudouin, J., Richter, P., Eils, R., Krammer, P.H., and Lavrik, I.N. (2010). Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL. J. Cell Biol. 190, 377-389.
28. Friedman, N., Cai, L., and Xie, X.S. (2006). Linking stochastic dynamics to population distribution: an analytical framework of gene expression. Phys. Rev. Lett. 97, 168302.
29. Fuentes-Prior, P., and Salvesen, G.S. (2004). The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 384, 201-232. (Pubitemid 39656233)
30. Fussenegger, M., Bailey, J.E., and Varner, J. (2000). A mathematical model of caspase function in apoptosis. Nat. Biotechnol. 18, 768-774.
31. Gascoigne, K.E., and Taylor, S.S. (2008). Cancer cells display profound intraand interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14, 111-122.
32. Geva-Zatorsky, N., Rosenfeld, N., Itzkovitz, S., Milo, R., Sigal, A., Dekel, E., Yarnitzky, T., Liron, Y., Polak, P., Lahav, G., et al. (2006). Oscillations and variability in the p53 system. Mol. Syst. Biol. 2, 2006.0033.
33. Gillespie, D.T. (1977). Exact stochastic simulation of coupled chemical reactions. J. Phys. Chem. 81, 2340-2361.
34. Goldstein, J.C., Kluck, R.M., and Green, D.R. (2000a). A single cell analysis of apoptosis. Ordering the apoptotic phenotype. Ann. N Y Acad. Sci. 926, 132-141.
35. Goldstein, J.C., Waterhouse, N.J., Juin, P., Evan, G.I., and Green, D.R. (2000b). The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat. Cell Biol. 2, 156-162.
36. Goldstein, J.C., Munoz-Pinedo, C., Ricci, J.E., Adams, S.R., Kelekar, A., Schuler, M., Tsien, R.Y., and Green, D.R. (2005). Cytochromec is released in a single step during apoptosis. Cell Death Differ. 12, 453-462. (Pubitemid 40662843)
37. Gonzalvez, F., and Ashkenazi, A. (2010). New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene 29, 4752-4765.
38. Green, D.R. (2011). Means to an End: Apoptosis and Other Cell Death Mechanisms (Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory Press).
39. Hellwig, C.T., Kohler, B.F., Lehtivarjo, A.K., Dussmann, H., Courtney, M.J., Prehn, J.H., and Rehm, M. (2008). Real time analysis of tumor necrosis factor-related apoptosis-inducing ligand/cycloheximide-induced caspase activities during apoptosis initiation. J. Biol. Chem. 283, 21676-21685.
40. Hellwig, C.T., Ludwig-Galezowska, A.H., Concannon, C.G., Litchfield, D.W., Prehn, J.H., and Rehm, M. (2010). Activity of protein kinase CK2 uncouples Bid cleavage from caspase-8 activation. J. Cell Sci. 123, 1401-1406.
41. Hengartner, M.O. (2000). The biochemistry of apoptosis. Nature 407, 770-776.
42. Hlavacek, W.S., Faeder, J.R., Blinov, M.L., Posner, R.G., Hucka, M., and Fontana, W. (2006). Rules for modeling signal-transduction systems. Sci. STKE 2006, re6.
43. Ho, K.L., and Harrington, H.A. (2010). Bistability in apoptosis by receptor clustering. PLoS Comput. Biol. 6, e1000956.
44. Hoffmann, A., Levchenko, A., Scott, M.L., and Baltimore, D. (2002). The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298, 1241-1245. (Pubitemid 35285493)
45. Hua, F., Cornejo, M.G., Cardone, M.H, Stokes, C.L., and Lauffenburger, D.A. (2005). Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. J. Immunol. 175, 985-995. (Pubitemid 41094983)
46. Huang, H.C., Mitchison, T.J., and Shi, J. (2010). Stochastic competition between mechanistically independent slippage and death pathways determines cell fate during mitotic arrest. PLoS One 5, e15724.
47. Jaqaman, K., and Danuser, G. (2006). Linking data to models: data regression. Nat. Rev. Mol. Cell Biol. 7, 813-819.
48. Jost, P.J., Grabow, S., Gray, D., McKenzie, M.D., Nachbur, U., Huang, D.C., Bouillet, P., Thomas, H.E., Borner, C., Silke, J., et al. (2009). XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 460, 1035-1039.
49. Kaufmann, S.H., and Earnshaw, W.C. (2000). Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42-49.
50. Kim, K.A., Spencer, S.L., Albeck, J.G., Burke, J.M., Sorger, P.K., Gaudet, S., and Kim do, H. (2010). Systematic calibration of a cell signaling network model. BMC Bioinformatics 11, 202.
51. Korsmeyer, S.J., Shutter, J.R., Veis, D.J., Merry, D.E., and Oltvai, Z.N. (1993). Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4, 327-332.
52. Krishna, S., Banerjee, B., Ramakrishnan, T.V., and Shivashankar, G.V. (2005). Stochastic simulations of the origins and implications of long-tailed distributions in gene expression. Proc. Natl. Acad. Sci. USA 102, 4771-4776.
53. Lavrik, I.N., Golks, A., Riess, D., Bentele, M., Eils, R., and Krammer, P.H. (2007). Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. J. Biol. Chem. 282, 13664-13671.
54. Lee, T.K., Denny, E.M., Sanghvi, J.C., Gaston, J.E., Maynard, N.D., Hughey, J.J., and Covert, M.W. (2009). A noisy paracrine signal determines the cellular NF-kappaB response to lipopolysaccharide. Sci. Signal. 2, ra65.
55. Legewie, S., Bluthgen, N., and Herzel, H. (2006). Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability. PLoS Comput. Biol. 2, e120.
56. Letai, A.G. (2008). Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat. Rev. Cancer 8, 121-132.
57. Lovell, J.F., Billen, L.P., Bindner, S., Shamas-Din, A., Fradin, C., Leber, B., and Andrews, D.W. (2008). Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 135, 1074-1084.
58. Lovric, M.M., and Hawkins, C.J. (2010). TRAIL treatment provokes mutations in surviving cells. Oncogene 29, 5048-5060.
59. Luan, D., Zai, M., and Varner, J.D. (2007). Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies. PLoS Comput. Biol. 3, e142.
60. Luo, K.Q., Yu, V.C., Pu, Y., and Chang, D.C. (2003). Measuring dynamics of caspase-8 activation in a single living HeLa cell during TNFalpha-induced apoptosis. Biochem. Biophys. Res. Commun. 304, 217-222.
61. Maas, C., Verbrugge, I., de Vries, E., Savich, G., van de Kooij, L.W., Tait, S.W., and Borst, J. (2010). Smac/DIABLO release from mitochondria and XIAP inhibition are essential to limit clonogenicity of type I tumor cells after TRAIL receptor stimulation. Cell Death Differ. 17, 1613-1623.
62. Madesh, M., Antonsson, B., Srinivasula, S.M., Alnemri, E.S., and Hajnoczky, G. (2002). Rapid kinetics of tBid-induced cytochrome c and Smac/DIABLO release and mitochondrial depolarization. J. Biol. Chem. 277, 5651-5659.
63. Nelson, D.E., Ihekwaba, A.E., Elliott, M., Johnson, J.R., Gibney, C.A., Foreman, B.E., Nelson, G., See, V., Horton, C.A., Spiller, D.G., et al. (2004). Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 306, 704-708. (Pubitemid 39440922)
64. Neumann, L., Pforr, C., Beaudouin, J., Pappa, A., Fricker, N., Krammer, P.H., Lavrik, I.N., and Eils, R. (2010). Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol. Syst. Biol. 6, 352.
65. Niepel, M., Spencer, S.L., and Sorger, P.K. (2009). Non-genetic cell-to-cell variability and the consequences for pharmacology. Curr. Opin. Chem. Biol. 13, 556-561.
66. Orth, J.D., Tang, Y., Shi, J., Loy, C.T., Amendt, C., Wilm, C., Zenke, F.T., and Mitchison, T.J. (2008). Quantitative live imaging of cancer and normal cells treated with Kinesin-5 inhibitors indicates significant differences in phenotypic responses and cell fate. Mol. Cancer Ther. 7, 3480-3489.
67. Ozbudak, E.M., Thattai, M., Lim, H.N., Shraiman, B.I., and Van Oudenaarden, A. (2004). Multistability in the lactose utilization network of Escherichia coli. Nature 427, 737-740. (Pubitemid 38294592)
68. Raj, A., and van Oudenaarden, A. (2008). Nature, nurture, or chance: stochastic gene expression and its consequences. Cell 135, 216-226.
69. Rehm, M., Dussmann, H., Janicke, R.U., Tavare, J.M., Kogel, D., and Prehn, J.H. (2002). Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process. Role of caspase-3. J. Biol. Chem. 277, 24506-24514.
70. Rehm, M., Dussmann, H., and Prehn, J.H. (2003). Real-time single cell analysis of Smac/DIABLO release during apoptosis. J. Cell Biol. 162, 1031-1043. (Pubitemid 37174186)
71. Rehm, M., Huber, H.J., Dussmann, H., and Prehn, J.H. (2006). Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J. 25, 4338-4349. (Pubitemid 44435231)
72. Rehm, M., Huber, H.J., Hellwig, C.T., Anguissola, S., Dussmann, H., and Prehn, J.H. (2009). Dynamics of outer mitochondrial membrane permeabilization during apoptosis. Cell Death Differ. 16, 613-623.
73. Reya, T., Morrison, S.J., Clarke, M.F., and Weissman, I.L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414, 105-111. (Pubitemid 33041634)
74. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K.J., Debatin, K.M., Krammer, P.H., and Peter, M.E. (1998). Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17, 1675-1687. (Pubitemid 28119121)
75. Schile, A.J., Garcia-Fernandez, M., and Steller, H. (2008). Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev. 22, 2256-2266.
76. Schutze, S., Tchikov, V., and Schneider-Brachert, W. (2008). Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat. Rev. Mol. Cell Biol. 9, 655-662.
77. Sharma, S.V., Lee, D.Y., Li, B., Quinlan, M.P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M.A., et al. (2010). A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69-80.
78. Sigal, A., Milo, R., Cohen, A., Geva-Zatorsky, N., Klein, Y., Liron, Y., Rosenfeld, N., Danon, T., Perzov, N., and Alon, U. (2006). Variability and memory of protein levels in human cells. Nature 444, 643-646. (Pubitemid 44864444)
79. Skeel, R.T. (2003). Handbook of Cancer Chemotherapy, Sixth Edition (Philadelphia: Lippincott Williams & Wilkins).
80. Spencer, S.L., Gaudet, S., Albeck, J.G., Burke, J.M., and Sorger, P.K. (2009). Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459, 428-432.
81. Stennicke, H.R., Renatus, M., Meldal, M., and Salvesen, G.S. (2000). Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem. J. 350, 563-568.
82. Sun, T., Lin, X., Wei, Y., Xu, Y., and Shen, P. (2010). Evaluating bistability of Bax activation switch. FEBS Lett. 584, 954-960.
83. Tait, S.W., Parsons, M.J., Llambi, F., Bouchier-Hayes, L., Connell, S., Munoz-Pinedo, C., and Green, D.R. (2010). Resistance to caspase-independent cell death requires persistence of intact mitochondria. Dev. Cell 18, 802-813.
84. Thornberry, N.A., Rano, T.A., Peterson, E.P., Rasper, D.M., Timkey, T., Garcia-Calvo, M., Houtzager, V.M., Nordstrom, P.A., Roy, S., Vaillancourt, J.P., et al. (1997). A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907-17911.
85. Tyas, L., Brophy, V.A., Pope, A., Rivett, A.J., and Tavare, J.M. (2000). Rapid caspase-3 activation during apoptosis revealed using fluorescence- resonance energy transfer. EMBO Rep. 1, 266-270.
86. Vaughan, A.T., Betti, C.J., and Villalobos, M.J. (2002). Surviving apoptosis. Apoptosis 7, 173-177. (Pubitemid 34273133)
87. Vaughan, A.T., Betti, C.J., Villalobos, M.J., Premkumar, K., Cline, E., Jiang, Q., and Diaz, M.O. (2005). Surviving apoptosis: a possible mechanism of benzene-induced leukemia. Chem. Biol. Interact. 153-154, 179-185.
88. Villalobos, M.J., Betti, C.J., and Vaughan, A.T. (2006). Detection of DNA double-strand breaks and chromosome translocations using ligation-mediated PCR and inverse PCR. Methods Mol. Biol. 314, 109-121.
89. von Ahsen, O., Renken, C., Perkins, G., Kluck, R.M., Bossy-Wetzel, E., and Newmeyer, D.D. (2000). Preservation of mitochondrial structure and function after Bid- or Bax-mediated cytochrome c release. J. Cell Biol. 150, 1027-1036.
90. Wagner, K.W., Punnoose, E.A., Januario, T., Lawrence, D.A., Pitti, R.M., Lancaster, K., Lee, D., von Goetz, M., Yee, S.F., Totpal, K., et al. (2007). Deathreceptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat. Med. 13, 1070-1077.
91. Wurstle, M.L., Laussmann, M.A., and Rehm, M. (2010). The caspase-8 dimerization/dissociation balance is a highly potent regulator of caspase-8, -3, -6 signaling. J. Biol. Chem. 285, 33209-33218.
92. Zhang, L., and Fang, B. (2005). Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther. 12, 228-237. (Pubitemid 40315182)
93. Zheng, Q., and Ross, J. (1991). Comparison of deterministic and stochastic kinetics for nonlinear systems. J. Chem. Phys. 94, 3644-3648.